He J, Sun S, Wang H, Ying Z, Tam K
Neurosci Bull. 2025; .
PMID: 39907971
DOI: 10.1007/s12264-025-01354-y.
Zhang S, Gao Z, Feng L, Li M
J Inflamm Res. 2024; 17:7235-7259.
PMID: 39421566
PMC: 11484773.
DOI: 10.2147/JIR.S483412.
Sarazin M, Lagarde J, El Haddad I, de Souza L, Bellier B, Potier M
Nat Aging. 2024; 4(6):761-770.
PMID: 38839924
DOI: 10.1038/s43587-024-00630-2.
Goo C, Morden F, Wong K, Aquino S, Kawamura J, Rubel V
Cureus. 2024; 15(12):e50001.
PMID: 38186481
PMC: 10767469.
DOI: 10.7759/cureus.50001.
Pomilio C, Presa J, Oses C, Vinuesa A, Bentivegna M, Gregosa A
Mol Neurobiol. 2024; 61(8):5142-5160.
PMID: 38172288
DOI: 10.1007/s12035-023-03897-5.
Proteomics revealed an association between ribosome-associated proteins and amyloid beta deposition in Alzheimer's disease.
Feng L, Wang G, Song Q, Feng X, Su J, Ji G
Metab Brain Dis. 2023; 39(2):263-282.
PMID: 38019374
DOI: 10.1007/s11011-023-01330-3.
Machine Learning Analysis of Alzheimer's Disease Single-Cell RNA-Sequencing Data across Cortex and Hippocampus Regions.
Krokidis M, Vrahatis A, Lazaros K, Skolariki K, Exarchos T, Vlamos P
Curr Issues Mol Biol. 2023; 45(11):8652-8669.
PMID: 37998721
PMC: 10670182.
DOI: 10.3390/cimb45110544.
Decision making in clinical trials: Interim analyses, innovative design, and biomarkers.
Welsh-Bohmer K, Kerchner G, Dhadda S, Garcia M, Miller D, Natanegara F
Alzheimers Dement (N Y). 2023; 9(4):e12421.
PMID: 37867532
PMC: 10585126.
DOI: 10.1002/trc2.12421.
Alzheimer's Disease from the Amyloidogenic Theory to the Puzzling Crossroads between Vascular, Metabolic and Energetic Maladaptive Plasticity.
Cerasuolo M, Papa M, Colangelo A, Rizzo M
Biomedicines. 2023; 11(3).
PMID: 36979840
PMC: 10045635.
DOI: 10.3390/biomedicines11030861.
A digital health home intervention for people within the Alzheimer's disease continuum: results from the Ability-TelerehABILITation pilot randomized controlled trial.
Rossetto F, Isernia S, Realdon O, Borgnis F, Blasi V, Pagliari C
Ann Med. 2023; 55(1):1080-1091.
PMID: 36929703
PMC: 10030155.
DOI: 10.1080/07853890.2023.2185672.
Beneficial Effect of ACI-24 Vaccination on Aβ Plaque Pathology and Microglial Phenotypes in an Amyloidosis Mouse Model.
Njavro J, Vukicevic M, Fiorini E, Dinkel L, Muller S, Berghofer A
Cells. 2023; 12(1).
PMID: 36611872
PMC: 9818422.
DOI: 10.3390/cells12010079.
Assessment of perfusion deficit with early phases of [F]PI-2620 tau-PET versus [F]flutemetamol-amyloid-PET recordings.
Volter F, Beyer L, Eckenweber F, Scheifele M, Bui N, Patt M
Eur J Nucl Med Mol Imaging. 2022; 50(5):1384-1394.
PMID: 36572740
PMC: 10027797.
DOI: 10.1007/s00259-022-06087-y.
Brain organoid-on-a-chip: A next-generation human brain avatar for recapitulating human brain physiology and pathology.
Song J, Bang S, Choi N, Kim H
Biomicrofluidics. 2022; 16(6):061301.
PMID: 36438549
PMC: 9691285.
DOI: 10.1063/5.0121476.
The emerging neuroprotective roles of exerkines in Alzheimer's disease.
Rody T, de Amorim J, De Felice F
Front Aging Neurosci. 2022; 14:965190.
PMID: 36118704
PMC: 9472554.
DOI: 10.3389/fnagi.2022.965190.
Effects of dose change on the success of clinical trials.
Shan G, Ritter A, Miller J, Bernick C
Contemp Clin Trials Commun. 2022; 30:100988.
PMID: 36117568
PMC: 9478360.
DOI: 10.1016/j.conctc.2022.100988.
Neuroinflammation represents a common theme amongst genetic and environmental risk factors for Alzheimer and Parkinson diseases.
Boyd R, Avramopoulos D, Jantzie L, McCallion A
J Neuroinflammation. 2022; 19(1):223.
PMID: 36076238
PMC: 9452283.
DOI: 10.1186/s12974-022-02584-x.
Interactive Effects of Pulse Pressure and Tau Imaging on Longitudinal Cognition.
Weigand A, Macomber A, Walker K, Edwards L, Thomas K, Bangen K
J Alzheimers Dis. 2022; 89(2):633-640.
PMID: 35938247
PMC: 9904538.
DOI: 10.3233/JAD-220026.
Aducanumab, a Novel Anti-Amyloid Monoclonal Antibody, for the Treatment of Alzheimer's Disease: A Comprehensive Review.
Haddad H, Malone G, Comardelle N, Degueure A, Kaye A, Kaye A
Health Psychol Res. 2022; 10(1):31925.
PMID: 35928986
PMC: 9346954.
DOI: 10.52965/001c.31925.
Aduhelm, a novel anti-amyloid monoclonal antibody, for the treatment of Alzheimer's Disease: A comprehensive review.
Haddad H, Malone G, Comardelle N, Degueure A, Poliwoda S, Kaye R
Health Psychol Res. 2022; 10(3):37023.
PMID: 35910244
PMC: 9334157.
DOI: 10.52965/001c.37023.
Is There a Connection between the Metabolism of Copper, Sulfur, and Molybdenum in Alzheimer's Disease? New Insights on Disease Etiology.
Coelho F, Cerchiaro G, Espirito Santo Araujo S, Daher J, Cardoso S, Coelho G
Int J Mol Sci. 2022; 23(14).
PMID: 35887282
PMC: 9324259.
DOI: 10.3390/ijms23147935.
